World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 12 March 2018
Main ID:  ChiCTR1800015158
Date of registration: 2018-03-11
Prospective Registration: Yes
Primary sponsor: Guangzhou Women and Children's Medical Center
Public title: A multicenter follow-up study of children's intestinal polyps in China
Scientific title: A multicenter follow-up study of children's intestinal polyps in China
Date of first enrolment: 2018-04-01
Target sample size: Case series:426;
Recruitment status: Pending
URL:  http://www.chictr.org.cn/showproj.aspx?proj=25856
Study type:  Epidemilogical research
Study design:  Cohort study  
Phase:  Other
Countries of recruitment
China
Contacts
Name: Lan-Lan Geng   
Address:  318 Renmin Road, Yuexiu District, Guangzhou, Guangdong, China
Telephone: +86 13622237569
Email: 13622237569@163.com
Affiliation:  Guangzhou Women and Children's Medical Center
Name: Shun-Xian Zhang   
Address:  318 Renmin Road, Yuexiu District, Guangzhou, Guangdong, China
Telephone: +86 15221367406
Email: zhangshunxian110@163.com
Affiliation:  Guangzhou Women and Children's Medical Center
Key inclusion & exclusion criteria
Inclusion criteria: From April 1, 2018 to December 31, 2027, patients with intestinal polyps treated in the hospital department were selected.
Exclusion criteria: (1) the person who had not received the informed consent;
(2) exclude the subjects with insufficient fecal samples, insufficient blood volume or no collection, intestinal polyps, intestinal mucosa without collection, incomplete questionnaires or refusal to participate.
(3) all patients were excluded from tuberculosis, hepatitis B virus (HBV), hepatitis C virus (HCV), HIV and other viral infections, excluding other chronic diseases such as diabetes, hypertension and rheumatoid arthritis and other autoimmune diseases.


Age minimum: 0
Age maximum: 18
Gender: Both
Health Condition(s) or Problem(s) studied
Intestinal polyps
Intervention(s)
Case series:NA;
Primary Outcome(s)
Days of hospitalization;
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Self-financing
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Li Qingfeng
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history